Study Claims Ozempic Lowers Biological Age
Researchers reveal that GLP-1 medication Ozempic may reduce biological age, offering new hope in the fight against aging and related health issues.
GLP-1 medications have proven to be incredibly versatile, originally developed as a treatment for diabetes, and later used for treating obesity and promoting weight loss.
According to a 32-week, double-blind, placebo-controlled trial by TruDiagnostic, Ozempic may reduce the user’s biologic age by just over three years.
Ozempic may reduce biological age, offering new hope in the fight against aging and related health issues.
The positive impact on weight-management makes the drugs helpful in treating conditions associated or impacted by obesity.
Author summary: Ozempic reduces biological age.